CIK 0001280776 · Non-accelerated filer<br>Smaller reporting company
IMMUNIC, INC.
Sign in to watch- Ticker
- IMUX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 562358443
- Phone
- (332) 255-9818
- Business address
- 1200 AVENUE OF THE AMERICAS, SUITE 200, NEW YORK, United States, 10036
- Former names
- VITAL THERAPIES INC
- 4 Open-market buy President and CEO bought 1,000 shares at $9.60 ($9,600)
- 4 Open-market buy Executive Chairman bought 1,000 shares at $9.80 ($9,800)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Executive Chairman bought 4,000 shares at $12.75 ($51,000)
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Chief Medical Officer bought 10,006 shares at $15.54 ($155,493)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy PFO and PAO bought 1,000 shares at $16.48 ($16,480)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy PFO and PAO bought 1,000 shares at $18.96 ($18,960)
- 4 Open-market sale Chief Operating Officer sold 5,650 shares at an average $14.58 ($82,355)
- 4 Open-market sale Chief Executive Officer sold 6,300 shares at an average $14.68 ($92,510)
Page 7 of 16 · 313 filings